| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |